Abstract
Background
The outcome of cardiac sarcoidosis is sometimes very poor. Ventricular tachycardia (VT) associated with cardiac sarcoidosis is the most common cause of sudden death among most patients. However, there is no established method for potential VT in patients with cardiac sarcoidosis. Thus, we investigated the utility of evaluation of gallium-67 scintigraphy for potential VT in patients with cardiac sarcoidosis.
Methods and Results
Cardiac sarcoidosis was diagnosed in 25 patients at ours or collaborating hospitals during the period 1982 through 2004. Twenty-one of these patients were treated with corticosteroid, and these patients were divided into two groups, depending on whether VT was present: a non-VT group (n=7) and a VT group (n=14). Laboratory and gallium-67 scintigraphy findings were examined in both groups. During the follow-up period, initial and maintenance dosages of corticosteroid did not differ significantly between the groups. Accumulation of gallium-67 in the heart at the time of diagnosis was detected more frequently in the VT group than in the non-VT group (14.3 vs. 71.4%, p<0.05). Six of the seven VT patients who underwent follow-up examination showed improvement on the scintigram obtained after treatment. Five of the six showed no VT recurrence in terms of Holter electrocardiogram, electrophysiologic study, or delivery of implantable cardioverter defibrillator shock. Serum angiotensin-converting enzyme and lysozyme concentrations were within normal limits in most patients in both groups.
Conclusions
Activity of sarcoid granulomas may be associated with the occurrence of VT. Gallium-67 scintigraphy reflects the activity of sarcoid granulomas and thus is useful for evaluation of cardiac sarcoidosis in patients with potential VT.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sekiguchi M, Yazaki Y, Isobe M, Hiroe M (1996) Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations. Cardiovasc Drugs Ther 10(5):495–510
Porter GH (1960) Sarcoid heart disease. N Engl J Med 263:1350–7
Gozo EG, Jr., Cosnow I, Cohen HC, Okun L (1971) The heart in sarcoidosis. Chest 60(4):379–88
Fleming HA (1974) Sarcoid heart disease. Br Heart J 36(1):54–68
Phinney AO, Jr. (1961) Sarcoid of the myocardial septum with complete heart block. Report of two cases. Am Heart J 62:270–6
Bashour FA, McConnell T, Skinner W, Hanson M (1968) Myocardial sarcoidosis. Dis Chest 53(4):413–20
Roberts WC, McAllister HA, Jr., Ferrans VJ (1977) Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 63(1):86–108
Silverman KJ, Hutchins GM, Bulkley BH (1978) Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58(6):1204–11
Okayama K, Kurata C, Tawarahara K, Wakabayashi Y, Chida K, Sato A (1995) Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest 107(2):330–4
Niden AH, Mishkin FS, Khurana MM (1976) 67Gallium citrate lung scans in interstitial lung disease. Chest 69(2 Suppl):266–8
Yoshida Y, Morimoto S, Hiramitsu S, Tsuboi N, Hirayama H, Itoh T (1997) Incidence of cardiac sarcoidosis in Japanese patients with high-degree atrioventricular block. Am Heart J 134(3):382–6
Yazaki Y, Isobe M, Hiroe M, Morimoto S, Hiramitsu S, Nakano T, et al. (2001) Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 88(9):1006–10
Virmani R, Bures JC, Roberts WC (1980) Cardiac sarcoidosis; a major cause of sudden death in young individuals. Chest 77(3):423–8
Furushima H, Chinushi M, Sugiura H, Kasai H, Washizuka T, Aizawa Y (2004) Ventricular tachyarrhythmia associated with cardiac sarcoidosis: its mechanisms and outcome. Clin Cardiol 27(4):217–22
Kurata C, Sakata K, Taguchi T, Fukumoto Y, Miyata H, Aoshima S, et al. (1990) SPECT imaging with Tl-201 and Ga-67 in myocardial sarcoidosis. Clin Nucl Med 15(6):408–11
Tomita H, Sato S, Matsuda R, Sugiura Y, Kawaguchi H, Niimi T, et al. (1999) Serum lysozyme levels and clinical features of sarcoidosis. Lung 177(3):161–7
Muller-Quernheim J (1998) Serum markers for the staging of disease activity of sarcoidosis and other interstitial lung diseases of unknown etiology. Sarcoidosis Vasc Diffuse Lung Dis 15(1):22–37
Lieberman J (1975) Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med 59(3):365–72
Selroos O, Klockars M (1977) Serum lysozyme in sarcoidosis. Evaluation of its usefulness in determination of disease activity. Scand J Respir Dis 58(2):110–6
Costabel U, Teschler H (1997) Biochemical changes in sarcoidosis. Clin Chest Med 18(4):827–42
Tawarahara K, Kurata C, Okayama K, Kobayashi A, Yamazaki N (1992) Thallium-201 and gallium 67 single photon emission computed tomographic imaging in cardiac sarcoidosis. Am Heart J 124(5):1383–4
Acknowledgment
The investigators thank Drs Nobuo Toshida and Naoto Yamamoto at Soka City Hospital and Dr Keiji Nishiyama at National Hospital Tokyo Disaster Medical Center for providing patient data for this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Futamatsu, H., Suzuki, Ji., Adachi, S. et al. Utility of gallium-67 scintigraphy for evaluation of cardiac sarcoidosis with ventricular tachycardia. Int J Cardiovasc Imaging 22, 443–448 (2006). https://doi.org/10.1007/s10554-005-9043-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-005-9043-x